Skip to main content
. 2023 Jul 19;9(29):eadg5358. doi: 10.1126/sciadv.adg5358

Fig. 1. Illustration of lung-targeting nanoengineered MSCs-Lip@NCAF designed to reverse PF in young and aged mice.

Fig. 1.

(A) Preparation of MSCs-Lip@NCAF. PC, phosphatidylcholine. (B) MSCs-Lip@NCAF migrated to injured lungs because of their homing ability, and Lip@NCAF was released in response to MMP-2. Then, Lip@NCAF degraded collagen fibers and inhibited fibroblast overactivation. Moreover, MSCs repaired injured AEC IIs in young mice and differentiated into AEC IIs to participate in alveolar reestablishment in aged mice.